Annalise Enterprise CXR is an advanced AI decision-support solution developed by clinicians for clinicians. It analyzes chest X-rays and detects up to 124 findings in under 20 seconds, acting as a second pair of eyes to enhance diagnostic accuracy and confidence. The solution is CE marked as a class IIb medical device and is available for clinical use in multiple regions including the EU, UK, Australia, India, and more.

Features

• Detection of 124 Findings: Covers a wide range of clinically relevant chest X-ray abnormalities.
• Rapid Analysis: Results available in less than 20 seconds.
• Multiview Correlation: Supports analysis of up to three images per study.
• Confidence Bar: Displays likelihood and uncertainty of findings to aid interpretation.
• Automated Draft Reporting: Generates editable reports integrated into routine workflows.
• Seamless Integration: Customizable UI integrates with PACS and RIS systems.
• Intuitive Design: Most clinicians feel comfortable using it after fewer than 10 studies.
• Extensive Training Dataset: Trained on 782,000+ unique CXR studies from diverse sources.
• Expert Annotation: Annotated by over 150 qualified radiologists using standardized procedures.
• Robust Labeling: Over 280 million CXR labels used for model training.

Benefits

• Improved Accuracy: Average 45% improvement across all analyzed findings.
• Greater Efficiency: 12% average improvement in reporting efficiency.
• Enhanced Confidence: Reduces fatigue and cognitive bias during interpretation.
• Better Patient Outcomes: Early detection of critical conditions like lung cancer.
• Clinician-Endorsed: Widely praised for usability and impact on care quality.
• Global Availability: CE marked and available in Australia, New Zealand, EU, UK, India, ASEAN*, UAE, and more.
• Scalable Deployment: Easily integrates into existing radiology workflows.